The Effect of Concave Healing Abutment on Soft Tissue Healing

Launched by MIS IMPLANT TECHNOLOGIES, LTD · Jul 27, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how a special type of dental implant piece called a concave healing abutment affects the healing of gum tissue compared to a straight abutment. The researchers want to see if using the concave design helps create more healthy gum tissue around dental implants, which are used to replace missing teeth.

To participate in this study, you should be at least 18 years old and need dental implants in the back of your upper or lower jaw. You should be in good overall health and able to attend all study visits. It's important that you have good oral hygiene and do not have any serious health conditions that could affect healing. If you qualify and decide to join, you can expect to have regular check-ups to monitor your healing process and the condition of your implants. Your participation could help improve dental implant procedures for others in the future!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • a) patients older than 18 years in need of implant therapy in the posterior area of the mandible and maxilla, b) good general/systemic health (ASA type I, II), c) patients who committed to attend all visits of the study, d) placement of a Ø 4.2 mm implant without requiring bone augmentation, e) adequate oral hygiene with FMPS (full mouth plaque score) \< 15% before surgery, f) absence of uncontrolled periodontal disease, g) agreeing to sign an informed consent.
• Exclusion Criteria:
• • a) patients with a contributing medical history in which any surgery, disease, condition, or medication susceptible to compromise the healing of soft and hard tissues (e.g. non-controlled diabetes), b) liver function disorder, c) immune system disease, d) immunosuppressant drugs, e) toxic habits other than smoking that might compromise or affect healing, f) patients who have undergone chemotherapy or radiation treatment during the previous 5 years comprising the head and neck area, g) corticosteroids therapy or any other medication that could influence postoperative healing and/or osseointegration, h) bisphosphonate or Denosumab therapy (Prolia®), i) sites that underwent or require a horizontal or vertical bone regeneration procedure, j) inability or unwillingness to attend follow-up visits, k) patients unwilling to sign an informed consent form.